Evaluation of the Use of Pneumonia Specific Antibiotics in the COVID - 19 Pandemic Situation at Glodok Surya Pharmacy Jakarta
DOI:
https://doi.org/10.26452/ijebr.v1i1.361Keywords:
Antibiotics, Pneumonia, Covid-19 Pandemic, Surya Glodok Pharmacy JakartaAbstract
The COVID-19 pandemic dominantly affects the use of antibiotics typical of pneumonia in particular at the Surya Glodok Pharmacy which is located in the trading area, Kota Tua, West Jakarta. The present study attempts to evaluate the use of pneumonia-specific antibiotics used during the COVID-19 pandemic at the Surya Glodok Pharmacy, Jakarta. 72 samples were taken retrospectively who met the inclusion criteria (complete prescriptions included gender and age and used pneumonia-specific antibiotics, or were excluded from pulmonary specialists or pulmonary hospitals, but not with comorbid tuberculosis). Data analysis was cross-sectional using SPSS software using one-way ANOVA analysis. There are 7 types of specific pneumonia antibiotics, namely: azithromycin (30.6%), ciprofloxacin (26.4%), levofloxacin (16.7%), amoxicillin plus clavulanate (11%), doxycycline (4%), moxifloxacin (2%), and cefixime plus azithromycin (2%). Patients' age was divided into 4 groups, namely: age <18 years (1.4%), age 18-40 years (29.2%), age 41-60 years (62.5%) and age > 60 years (6.9%). Gender was dominated by 51.39% female and 48.61% male. The most selected antibiotic was the azithromycin as macrolide group, dominated by the female in the middle class (productive age) with high activity outside the home.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 International Journal of Experimental and Biomedical Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.